Dhara B. Waghela

Do Your Medical Director Arrangements Meet The Top Five Best Practices?

PE Firms Face Liability For The Conduct Of Their Portfolio Companies: Are You Paying Attention?

Putting The Brakes On Healthcare M&A And Provider/Payor Contracting: AB 2080 Poised To Dramatically Impact Healthcare Transactions In California

HIPAA And COVID-19 Vaccination Status: The Office Of Civil Rights Issues Workplace Guidance

Executive Order On Promoting Competition In The American Economy: The Biden Administration Considers Drug Pricing Strategies While Keeping The "Most Favored Nations" Drug Reimbursement Program On The Sidelines

The American Rescue Plan Act Of 2021: A New Lease On Life For The Affordable Care Act?

Medicare Part B Most Favored Nation Drug Pricing Model: New Rules, New Lawsuits, New Tweets

ERISA: The Erosion Of State Health Regulation Rights

The Death Of RBG…and The ACA?

The Next In The Series Of Executive Orders Affecting The Pharmaceutical Industry

President Trump's Executive Order Mandating The Purchase Of U.S. Drugs Evokes Criticism

The California Department Of Managed Health Care Extends The Phase-In Period For The General Licensure Regulation

Telehealth And Online Prescribing: COVID-19 Triggers Changes To The Prescriber/Patient/Pharmacist Relationship

Supreme Court Issues Long Awaited Ruling On Affordable Care Act Risk Corridors Program

California Department Of Managed Health Care Releases Additional Guidance On Telehealth Services

Coronavirus Aid, Relief, And Economic Security Act Of 2020: Telehealth Front And Center

California Health Plans Take Note: California Department Of Managed Health Care Issues All Plan Letter On Social Distancing And COVID-19

ACA Medicaid Expansion Weakens: Trump Administration Unveils Optional Plan For Block Grants